跳至主導覽 跳至搜尋 跳過主要內容

Hyperuricemia and progression of chronic kidney disease: A review from physiology and pathogenesis to the role of urate-lowering therapy

  • Chang Gung University

研究成果: 期刊稿件 › 文獻綜述 › 同儕審查

63 引文 斯高帕斯(Scopus)

摘要

The relationship between hyperuricemia, gout, and renal disease has been investigated for several years. From the beginning, kidney disease has been considered a complication of gout; however, the viewpoints changed, claiming that hypertension and elevated uric acid (UA) levels are caused by decreased urate excretion in patients with renal impairment. To date, several examples of evidence support the role of hyperuricemia in cardiovascular or renal diseases. Several mechanisms have been identified that explain the relationship between hyperuricemia and chronic kidney disease, including the crystal effect, renin–angiotensin–aldosterone system activation, nitric oxide synthesis inhibition, and intracellular oxidative stress stimulation, and urate-lowering therapy (ULT) has been proven to reduce renal disease progression in the past few years. In this comprehensive review, the source and physiology of UA are introduced, and the mechanisms that explain the reciprocal relationship between hyperuricemia and kidney disease are reviewed. Lastly, current evidence supporting the use of ULT to postpone renal disease progression in patients with hyperuricemia and gout are summarized.

原文英語
文章編號1674
期刊Diagnostics
卷11
發行號9
DOIs
出版品狀態已出版 - 09 2021

文獻附註

Publisher Copyright:
© 2021 by the authors. Licensee MDPI, Basel, Switzerland.

UN SDG

此研究成果有助於以下永續發展目標

  1. SDG3 健康與福祉
    SDG3 健康與福祉

指紋

深入研究「Hyperuricemia and progression of chronic kidney disease: A review from physiology and pathogenesis to the role of urate-lowering therapy」主題。共同形成了獨特的指紋。

引用此